Stellus Rx Expands Through Acquisition
Stellus Rx, headquartered in Plano, Texas, has acquired Tria Health, according to PE Hub. This deal involves the technology-enabled pharmacy care management platform backed by WindRose, as detailed in the report dated 16 April 2026.
Background on Stellus Rx
Stellus Rx operates as a technology-enabled pharmacy care management platform and is based in Plano, Texas, according to the PE Hub article. The company is backed by WindRose, which positions it within the healthcare sector.
Details of the Acquisition
The acquisition of Tria Health by WindRose-backed Stellus Rx was announced in the PE Hub coverage. According to PE Hub, this move aligns with activities in the US healthcare space, as indicated by the article’s tags. The report, published on 16 April 2026, highlights Stellus Rx’s role in pharmacy care management.
Sector Context
As widely known, the healthcare industry often features strategic acquisitions, and this deal involves US-based entities, per the PE Hub tags of ‘Healthcare’ and ‘US’.
